Company chart and information is provided by TradingView based on 15-minute-delayed data.
Pharvaris NV is a clinical-stage company. It is focused on the discovery and development of novel oral bradykinin B2-receptor antagonists for the treatment of hereditary angioedema (HAE) and other bradykinin B2-receptor-mediated indications.
Website: | www.pharvaris.com |
Email: | info@pharvaris.com |
Main Phone: | +31 712036410 |
Address: | J.H. Oortweg 21 |
City / Town: | Leiden |
Country: | NL |
Postal Code: | 2333 CH |
Exchange: | NGS |
CEO: | Berndt Modig |
Employees: | 14 |
Last Price N/A | Change $ N/A | Change % N/A | Tick N/A |
Bid N/A | Bid Size N/A | Ask N/A | Ask Size N/A |
Open N/A | High N/A | Low N/A | Prev Close N/A |
Last Trade | Volume N/A | 52 Wk Hi N/A | 52 Wk Low N/A |
Market Cap N/A | Ex-Div Date N/A | Div Rate N/A | Yield N/A |
Shares N/A | EPS (TTM) N/A | PE Ratio N/A | Exchange N/A |